Search results: x Variables,
w Analyses, x Documents, and
z Datasets in
x Studies
| This analysis of association between allele and the AMD status variable (amdstat) from the National Eye Institute Age-Related Eye Disease Study (AREDS) was pre-computed by NCBI . It contained 350 cases and 171 controls. Genotyping was conducted by the Center for Inherited Disease Research (CIDR) using Affymetrix GeneChip Human Mapping 100K Set |
| This analysis of association between genotype and the AMD status variable (AMDSTAT) from the National Eye Institute Age-Related Eye Disease Study (AREDS) was pre-computed by NCBI . It contained 381 cases and 187 controls. The case group includes individuals whose final AMD phenotype is neovascular AMD (197), geographic atrophy (133), or both neovascular AMD and geographic atrophy (51). The control group includes individuals whose final AMD phenotype is Control (151), Control Questionable 1 (14), Control Questionable 2 (1), or Control Questionable 4 (21). Participants whose final AMD phenotype is Large Drusen (2), Large Drusen Questionable 2 (1), Questionable Advanced AMD (12), or Other, non-control (10) were not included in the analyses. Participants were originally selected for genotyping prior to final AMD phenotype information being available. Analyses are adjusted for age at last fundus photograph, gender, and smoking status at baseline. Genotyping was conducted by the Center for Inherited Disease Research (CIDR) using the Illumina Sentrix Human-1 Genotyping Beadchip. |
| This analysis of association between allele and the AMD status variable (amdstat) from the National Eye Institute Age-Related Eye Disease Study (AREDS) was pre-computed by NCBI . It contained 395 cases and 198 controls. Case individuals have been diagnosed as having non-vascular AMD (198), geographic atrophy (133), both non-vascular AMD and geographic atrophy (50), or large drusen (14). Genotyping was conducted by the Center for Inherited Disease Research (CIDR) using the Illumina Sentrix Human-1 Genotyping Beadchip. |